PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1135016
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1135016
Global Non-Animal Alternative Testing Market Size study, By Technology By Method, End User and Regional Forecasts 2022-2028
Global Non-Animal Alternative Testing Market is valued approximately USD 9.8 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 13.50% over the forecast period 2022-2028. Non-Animal Alternative Testing is a testing procedure that does not utilize animals to establish safety requirements for products such as pharmaceuticals and cosmetics. Drugs and cosmetics are tested using non-animal alternatives some of the methodologies utilized include organs-on-chip, in-vitro testing, and in-silico testing. The rising prevalence of chronic diseases and increase in usage of organs-on-chip technology as well as Strategic initiatives from leading market players are key factors accelerating the growth of the Market. According to - National Health Council USA - as of 2020, around 40 million American citizens are limited in their usual activities due to one or more chronic health conditions. In addition, around 133 million U.S. citizens are affected by chronic diseases, representing more than 40% of the total population of the country. Moreover, authorities across the globe are approving non-animal testing methods, this factor would influence the growth of the market during the forecast period. For instance, in 2021, the Organisation for economic co-opertation and development approved their first overall testing strategy to predict skin allergic reactions without the application of animal testing. Also, increasing favorable initiatives from authorities to ban the usage of animals in drug testing and growing advancements in In-vitro testing would create lucrative opportunities for the Market during the forecast period. However, a lack of awareness impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Non-Animal Alternative Testing Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region due to factors such as the rising incidence of chronic diseases as well as the presence of leading market players in the region. Whereas the Asia-Pacific market is anticipated to be the fastest growing region due to the rising ban on using animals in pre-clinical testing. In addition, leading market players are now investing in the introduction of new products in the region to support the development of research facilities and activities. In the coming years, these factors are projected to fuel the market expansion for non-animal alternative testing.
Major market players included in this report are:
VITROCELL Systems GmbH
Evotec SE
Biovit
MB Research Laboratories
Emulate, Inc.
TARA Biosystems, Inc.
Bio-Rad Laboratories, Inc.
Abbott
Hurel Corporation
TissUse GmbH
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Cell Culture
High Throughput
Molecular Imaging
OMIC Technology
By Method:
Cellular Assay
Biochemical Assay
In-silico
Ex-vivo
By End User:
Pharmaceutical Industry
Cosmetics & Household Products
Diagnostics
Chemicals Industry
Food Industry
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period: - 2022 to 2028
Target Audience of the Global Non-Animal Alternative Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Global Non-Animal Alternative Testing Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Global Non-Animal Alternative Testing Market, by Technology, 2020-2028 (USD Billion)
- 1.2.3. Global Non-Animal Alternative Testing Market, by Method, 2020-2028 (USD Billion)
- 1.2.4. Global Non-Animal Alternative Testing Market, by End User, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Non-Animal Alternative Testing Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Non-Animal Alternative Testing Market Dynamics
- 3.1. Non-Animal Alternative Testing Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising prevalence of chronic diseases
- 3.1.1.2. Increase in usage of organs-on-chip technology.
- 3.1.1.3. Strategic initiatives from leading market players.
- 3.1.2. Market Challenges
- 3.1.2.1. Legal requirement for animal testing in some countries.
- 3.1.3. Market Opportunities
- 3.1.3.1. Favourable initiatives from authorities to ban the usage of animals in drug testing
- 3.1.3.2. Growing advancements in In-vitro testing.
- 3.1.1. Market Drivers
Chapter 4. Global Non-Animal Alternative Testing Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Non-Animal Alternative Testing Market, by Technology
- 6.1. Market Snapshot
- 6.2. Global Non-Animal Alternative Testing Market by Technology, Performance - Potential Analysis
- 6.3. Global Non-Animal Alternative Testing Market Estimates & Forecasts by Technology 2018-2028 (USD Billion)
- 6.4. Non-Animal Alternative Testing Market, Sub Segment Analysis
- 6.4.1. Cell Culture
- 6.4.2. High Throughput
- 6.4.3. Molecular Imaging
- 6.4.4. OMIC Technology
Chapter 7. Global Non-Animal Alternative Testing Market, by Method
- 7.1. Market Snapshot
- 7.2. Global Non-Animal Alternative Testing Market by Method, Performance - Potential Analysis
- 7.3. Global Non-Animal Alternative Testing Market Estimates & Forecasts by Method 2018-2028 (USD Billion)
- 7.4. Non-Animal Alternative Testing Market, Sub Segment Analysis
- 7.4.1. Cellular Assay
- 7.4.2. Biochemical Assay
- 7.4.3. In-silico
- 7.4.4. Ex-vivo
Chapter 8. Global Non-Animal Alternative Testing Market, by End User
- 8.1. Market Snapshot
- 8.2. Global Non-Animal Alternative Testing Market by End User, Performance - Potential Analysis
- 8.3. Global Non-Animal Alternative Testing Market Estimates & Forecasts by End User 2018-2028 (USD Billion)
- 8.4. Non-Animal Alternative Testing Market, Sub Segment Analysis
- 8.4.1. Pharmaceutical Industry
- 8.4.2. Cosmetics & Household Products
- 8.4.3. Diagnostics
- 8.4.4. Chemicals Industry
- 8.4.5. Food Industry
Chapter 9. Global Non-Animal Alternative Testing Market, Regional Analysis
- 9.1. Non-Animal Alternative Testing Market, Regional Market Snapshot
- 9.2. North America Non-Animal Alternative Testing Market
- 9.2.1. U.S. Non-Animal Alternative Testing Market
- 9.2.1.1. Technology estimates & forecasts, 2018-2028
- 9.2.1.2. Method estimates & forecasts, 2018-2028
- 9.2.1.3. End User estimates & forecasts, 2018-2028
- 9.2.2. Canada Non-Animal Alternative Testing Market
- 9.2.1. U.S. Non-Animal Alternative Testing Market
- 9.3. Europe Non-Animal Alternative Testing Market Snapshot
- 9.3.1. U.K. Non-Animal Alternative Testing Market
- 9.3.2. Germany Non-Animal Alternative Testing Market
- 9.3.3. France Non-Animal Alternative Testing Market
- 9.3.4. Spain Non-Animal Alternative Testing Market
- 9.3.5. Italy Non-Animal Alternative Testing Market
- 9.3.6. Rest of Europe Non-Animal Alternative Testing Market
- 9.4. Asia-Pacific Non-Animal Alternative Testing Market Snapshot
- 9.4.1. China Non-Animal Alternative Testing Market
- 9.4.2. India Non-Animal Alternative Testing Market
- 9.4.3. Japan Non-Animal Alternative Testing Market
- 9.4.4. Australia Non-Animal Alternative Testing Market
- 9.4.5. South Korea Non-Animal Alternative Testing Market
- 9.4.6. Rest of Asia Pacific Non-Animal Alternative Testing Market
- 9.5. Latin America Non-Animal Alternative Testing Market Snapshot
- 9.5.1. Brazil Non-Animal Alternative Testing Market
- 9.5.2. Mexico Non-Animal Alternative Testing Market
- 9.6. Rest of The World Non-Animal Alternative Testing Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. VITROCELL Systems GmbH
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. Evotec SE
- 10.2.3. Biovit
- 10.2.4. MB Research Laboratories
- 10.2.5. Emulate, Inc.
- 10.2.6. TARA Biosystems, Inc.
- 10.2.7. Bio-Rad Laboratories, Inc.
- 10.2.8. Abbott
- 10.2.9. Hurel Corporation
- 10.2.10. TissUse GmbH
- 10.2.1. VITROCELL Systems GmbH
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Non-Animal Alternative Testing Market, report scope
- TABLE 2. Global Non-Animal Alternative Testing Market estimates & forecasts by Region 2018-2028 (USD Billion)
- TABLE 3. Global Non-Animal Alternative Testing Market estimates & forecasts by Technology 2018-2028 (USD Billion)
- TABLE 4. Global Non-Animal Alternative Testing Market estimates & forecasts by Method 2018-2028 (USD Billion)
- TABLE 5. Global Non-Animal Alternative Testing Market estimates & forecasts by End User 2018-2028 (USD Billion)
- TABLE 6. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 7. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 8. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 9. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 10. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 11. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 12. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 13. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 14. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 15. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 16. U.S. Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 17. U.S. Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 18. U.S. Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 19. Canada Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 20. Canada Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 21. Canada Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 22. UK Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 23. UK Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 24. UK Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 25. Germany Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 26. Germany Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 27. Germany Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 28. RoE Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 29. RoE Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 30. RoE Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 31. China Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 32. China Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 33. China Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 34. India Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 35. India Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 36. India Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 37. Japan Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 38. Japan Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 39. Japan Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 40. RoAPAC Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 41. RoAPAC Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 42. RoAPAC Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 43. Brazil Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 44. Brazil Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 45. Brazil Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 46. Mexico Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 47. Mexico Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 48. Mexico Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 49. RoLA Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 50. RoLA Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 51. RoLA Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 52. Row Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 53. Row Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 54. Row Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 55. List of secondary sources, used in the study of global Non-Animal Alternative Testing Market
- TABLE 56. List of primary sources, used in the study of global Non-Animal Alternative Testing Market
- TABLE 57. Years considered for the study
- TABLE 58. Exchange rates considered
LIST OF FIGURES
List of figures
- FIG 1. Global Non-Animal Alternative Testing Market, research methodology
- FIG 2. Global Non-Animal Alternative Testing Market, market estimation techniques
- FIG 3. Global market size estimates & forecast methods
- FIG 4. Global Non-Animal Alternative Testing Market, key trends 2021
- FIG 5. Global Non-Animal Alternative Testing Market, growth prospects 2022-2028
- FIG 6. Global Non-Animal Alternative Testing Market, porters 5 force model
- FIG 7. Global Non-Animal Alternative Testing Market, pest analysis
- FIG 8. Global Non-Animal Alternative Testing Market, value chain analysis
- FIG 9. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
- FIG 10. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
- FIG 11. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
- FIG 12. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
- FIG 13. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
- FIG 14. Global Non-Animal Alternative Testing Market, regional snapshot 2018 & 2028
- FIG 15. North America Non-Animal Alternative Testing Market 2018 & 2028 (USD Billion)
- FIG 16. Europe Non-Animal Alternative Testing Market 2018 & 2028 (USD Billion)
- FIG 17. Asia pacific market 2018 & 2028 (USD Billion)
- FIG 18. Latin America Non-Animal Alternative Testing Market 2018 & 2028 (USD Billion)
- FIG 19. Global Non-Animal Alternative Testing Market, company market share analysis (2021)
